Feb 11, 2021 at 7:30 AM EST
Keyword Search
- Summary ToggleInfinity Announces Closing of $92 Million Public Offering of Common StockFebruary 18, 2021 at 8:30 AM EST
- Summary ToggleInfinity Announces Pricing of $80 Million Public Offering of Common StockFebruary 12, 2021 at 8:30 AM EST
- Summary ToggleInfinity Announces Proposed Public Offering of Common StockFebruary 11, 2021 at 4:01 PM EST
- Summary ToggleInfinity Pharmaceuticals to Present at Upcoming BIO CEO & Investor ConferenceFebruary 11, 2021 at 9:25 AM EST
- Summary ToggleInfinity Pharmaceuticals to Participate in B. Riley Securities Virtual Oncology Investor ConferenceJanuary 15, 2021 at 8:35 AM EST
- Summary ToggleInfinity Pharmaceuticals to Participate in Three Investor Conferences This MonthJanuary 7, 2021 at 8:35 AM EST
- Summary ToggleInfinity Pharmaceuticals Provides Update for Eganelisib in Patients with Metastatic Urothelial CancerJanuary 6, 2021 at 9:11 AM EST